Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-25 @ 3:01 AM
NCT ID:
NCT02200133
Eligibility Criteria:
Inclusion Criteria:
* Adult (≥ 18 years at time of allogeneic HCT recipient at participating transplant centers)
* Survival 1-2 years after most recent HCT with no evidence of relapse, disease progression, or secondary cancer on last follow-up
* All diagnoses will be eligible
* All transplant types will be eligible (autologous or allogeneic related or unrelated)
* All graft sources will be eligible (bone marrow, peripheral blood or umbilical cord blood)
* All conditioning regimens will be eligible (in case of allogeneic HCT, patient could have received myeloablative or non-myeloablative/reduced-intensity conditioning)
* Patient may have received more than one HCT
* Patient must be proficient in English (written and spoken) to complete study assessments
* Patient must have a valid mailing address within the United States to receive study materials
* Signed informed consent form from patient
Exclusion Criteria:
\- Patients who have received their transplant at a different transplant center will not be eligible for the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02200133
Study Brief:
Protocol Section:
NCT02200133